Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|February 5, 2002
Considerations in the treatment of anxiety disorders: a pharmacoeconomic reviewA N GrudzinskiMedical Interface|September 4, 1996
Selected topical antifungal use in managed careS J Rich, A N GrudzinskiPharmacoeconomics|October 28, 1999
The economics of multiple sclerosis. Distribution of costs and relationship to disease severityA N Grudzinski, Z Hakim, E R Cox, et al.The American Journal of Managed Care|October 28, 1999
Course and cost of treatment for depression with fluoxetine, paroxetine, and sertralineJ M Russell, E R Berndt, R Miceli, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 9, 2006
Comparing SSRI treatment costs for depression using retrospective claims data: the role of nonrandom selection and skewed dataE R Berndt, J M Russell, R Miceli, et al.The Journal of Clinical Psychiatry|October 30, 2001
The effect of selective serotonin reuptake inhibitor treatment of panic disorder on emergency room and laboratory resource utilizationP P Roy-Byrne, C M Clary, R J Miceli, et al.Pageof 1